You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Oxaliplatin

Showing 2501 - 2525 of 2,879
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer Trial in United States (oxaliplatin, paclitaxel)

Completed
  • Lung Cancer
  • Chicago, Illinois
  • +10 more
Feb 8, 2013

Stomach Tumors Trial in Worldwide (Docetaxel + Oxaliplatin, Docetaxel + Oxaliplatin + 5-FU, Docetaxel + Oxaliplatin +

Completed
Has Results
  • Stomach Neoplasms
  • Docetaxel + Oxaliplatin
  • +2 more
  • Bridgewater, New Jersey
  • +11 more
Dec 19, 2012

Solid Tumor Trial in Bronx, New York (fluorouracil, gemcitabine HCl, oxaliplatin)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Bronx, New York
  • +1 more
Feb 8, 2013

Stage II Colon Cancer, Stage III Colon Cancer Trial in Pittsburgh (leucovorin calcium, fluorouracil, oxaliplatin)

Completed
  • Stage II Colon Cancer
  • Stage III Colon Cancer
  • leucovorin calcium
  • +3 more
  • Pittsburgh, Pennsylvania
    National Surgical Adjuvant Breast and Bowel Project
Jan 10, 2013

Rectal Cancer Trial in Harbin (Capecitabine, XELOX)

Unknown status
  • Rectal Cancer
  • Harbin, Heilongjiang, China
    Harbin Medical University Cancer Hospital
Dec 23, 2013

Head Neck Cancer Trial in United States (oxaliplatin)

Completed
  • Head and Neck Cancer
  • oxaliplatin
  • Chicago, Illinois
  • +10 more
Jan 30, 2013

Gastric Cancer Trial in Seoul (DOCETAXEL, S-1, OXALIPLATIN)

Completed
  • Gastric Cancer
  • Seoul, Korea, Republic of
    Sanofi-Aventis Administrative Office
Dec 17, 2012

Angioimmunoblastic T-cell Lymphoma, MALT, Nodal Marginal Zone B-cell Lymphoma Trial in Houston (oxaliplatin)

Completed
  • Angioimmunoblastic T-cell Lymphoma
  • +16 more
  • oxaliplatin
  • Houston, Texas
    M D Anderson Cancer Center
Jan 22, 2013

Metastatic Colorectal Cancer Trial in Seoul (Regorafenib/FOLFOX, Placebo/FOLFOX)

Withdrawn
  • Metastatic Colorectal Cancer
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Mar 12, 2013

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Boston (bevacizumab, oxaliplatin,

Completed
  • Adenocarcinoma of the Colon
  • +7 more
  • bevacizumab
  • +3 more
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
Jan 23, 2013

Colorectal Tumors Trial in Germany (Regorafenib (BAY73-4506))

Completed
  • Colorectal Neoplasms
  • Regorafenib (BAY73-4506)
  • Freiburg, Baden-Württemberg, Germany
  • +6 more
May 30, 2014

Esophageal Cancer, Gastric Cancer Trial in Puerto Rico, United States (FOLFOX regimen, fluorouracil, leucovorin calcium)

Completed
  • Esophageal Cancer
  • Gastric Cancer
  • FOLFOX regimen
  • +3 more
  • New Haven, Connecticut
  • +21 more
Feb 8, 2013

Stage IV Colorectal Cancer Trial in Germany (Oxaliplatin, Capecitabine, Bevacizumab, Imatinib)

Completed
  • Stage IV Colorectal Cancer
  • Oxaliplatin, Capecitabine, Bevacizumab, Imatinib
  • Cologne, NRW, Germany
  • +7 more
Jan 4, 2013

Colorectal Cancer, Metastatic Cancer Trial in New York (FOLFOX regimen, dexamethasone, floxuridine)

Completed
  • Colorectal Cancer
  • Metastatic Cancer
  • FOLFOX regimen
  • +5 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jan 17, 2013

Solid Tumor, Cancer Trial in Harvey, Durham, Nashville (capecitabine/oxaliplatin/bevacizumab/RAD001 (XELOX-A-Ev))

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Cancer
  • capecitabine/oxaliplatin/bevacizumab/RAD001 (XELOX-A-Ev)
  • Harvey, Illinois
  • +2 more
Dec 21, 2012

Inoperable Esophageal Cancer Stage I-III Trial in Lianyungang (Raltitrexed, Oxaliplatin, Radiotherapy)

Unknown status
  • Inoperable Esophageal Cancer Stage I-III
  • Lianyungang, Jiangsu, China
    The First People's Hospital of Lianyungang
Nov 19, 2012

Colorectal Cancer Trial in Ireland, United Kingdom (cetuximab, capecitabine, fluorouracil)

Unknown status
  • Colorectal Cancer
  • cetuximab
  • +4 more
  • Cork, Ireland
  • +81 more
Sep 16, 2013

Colorectal Tumors Trial in Worldwide (Bevacizumab (avastin), FOLFIRI (Irinotecan, leucovorin, 5-fluorouracil [5FU]), AG-013736

Completed
Has Results
  • Colorectal Neoplasms
  • Bevacizumab (avastin)
  • +4 more
  • Mobile, Alabama
  • +82 more
Apr 12, 2013

Colorectal Cancer Trial in Shimonagakubo Nagaizumi-cho Sunto-gun (SOL(The combination therapy of S-1, Leucovorin, and

Completed
  • Colorectal Cancer
  • SOL(The combination therapy of S-1, Leucovorin, and Oxaliplatin)
  • mFOLFOX6(The combination therapy of 5-FU, l-LV and Oxaliplatin)
  • Shimonagakubo Nagaizumi-cho Sunto-gun, Shizuoka, Japan
    Shizuoka Cancer Center
Oct 31, 2012

Colorectal Carcinoma Trial in Worldwide (Endoxana, Leukine, IMA910, Endoxana, Leukine, IMA910, Aldara)

Completed
  • Colorectal Carcinoma
  • Endoxana, Leukine, IMA910
  • Endoxana, Leukine, IMA910, Aldara
  • Bonheiden, Belgium
  • +40 more
May 15, 2013

Oesophago-gastric Cancer Trial in United Kingdom (epirubicin, oxaliplatin, capecitabine (EOX), EOX + panitumumab)

Terminated
  • Oesophago-gastric Cancer
  • epirubicin, oxaliplatin, capecitabine (EOX)
  • EOX + panitumumab
  • Bournemouth, United Kingdom
  • +6 more
Dec 10, 2012

Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer Trial in United States (irinotecan HCl, leucovorin

Terminated
Has Results
  • Recurrent Colon Cancer
  • +5 more
  • irinotecan hydrochloride
  • +4 more
  • Ft. Smith, Arkansas
  • +381 more
Jul 25, 2014

Child Solid Tumor Trial in Memphis (oxaliplatin)

Completed
  • Unspecified Childhood Solid Tumor, Protocol Specific
  • oxaliplatin
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 22, 2012

Gastrointestinal Cancer Trial in Houston (Capecitabine, Oxaliplatin)

Completed
Has Results
  • Gastrointestinal Cancer
  • Houston, Texas
    U.T. M.D. Anderson Cancer Center
Oct 22, 2012

Adenocarcinoma of the Rectum, Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum Trial in Boston

Completed
  • Adenocarcinoma of the Rectum
  • +8 more
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
Jan 9, 2013